Kim, Sunkyu
Korea University · NAVER Cloud (South Korea) · Naver (South Korea)
8 papers on CoChatORCID 0000-0002-0240-6210
Most cited papers
- Verified
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
Lee, J., Yoon, W., Kim, S., Kim, D., Kim, S., So, C. H., & Kang, J. (2020) · Bioinformatics
Biomedical Text Mining and OntologiesTopic Modeling
Cited by 7,218
- Verified
Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
Turnbull, A. P., Ioannidis, S., Krajewski, W. W., Pinto-Fernandez, A., Heride, C., Martin, A. C. L., Tonkin, L. M., Townsend, E. C., Buker, S. M., Lancia, D. R., et al. (2017) · Nature
Ubiquitin and proteasome pathwaysProtein Degradation and Inhibitors
Cited by 463
- Verified
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors
Vora, S. R., Juric, D., Kim, N., Mino-Kenudson, M., Huynh, T., Costa, C., Lockerman, E. L., Pollack, S. F., Liu, M., Li, X., et al. (2014) · Cancer Cell
PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies
Cited by 438
- Verified
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
Rader, J., Russell, M. R., Hart, L. S., Nakazawa, M. S., Belcastro, L. T., Martinez, D., Li, Y., Carpenter, E. L., Attiyeh, E. F., Diskin, S. J., et al. (2013) · Clinical Cancer Research
Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases
Cited by 394
- Verified
Antiproliferative Effects of CDK4/6 Inhibition in CDK4 -Amplified Human Liposarcoma In Vitro and In Vivo
Zhang, Y.-X., Sicinska, E., Czaplinski, J. T., Remillard, S. P., Moss, S., Wang, Y., Brain, C., Loo, A., Snyder, E. L., Demetri, G. D., et al. (2014) · Molecular Cancer Therapeutics
Sarcoma Diagnosis and TreatmentCancer-related Molecular Pathways
Cited by 114
- Verified
ChimerDB 4.0: an updated and expanded database of fusion genes
Jang, Y. E., Jang, I., Kim, S., Cho, S., Kim, D., Kim, K., Kim, J., Hwang, J., Kim, S., Kim, J., et al. (2019) · Nucleic Acids Research
Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities
Cited by 108
- Verified
Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer.
Kim, S., Loo, A., Chopra, R., Caponigro, G., Huang, A., Vora, S., Parasuraman, S., Howard, S., Keen, N., Sellers, W., et al. (2013) · Molecular Cancer Therapeutics
Advanced Breast Cancer TherapiesCancer-related Molecular Pathways
Cited by 106
- Verified
Improved survival analysis by learning shared genomic information from pan-cancer data
Kim, S., Kim, K., Choe, J., Lee, I., & Kang, J. (2020) · Bioinformatics
Gene expression and cancer classificationMachine Learning in Healthcare
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free